RxDoctor Payments Data

Brian Lee, MD

Otolaryngology/Facial Plastic Surgery · Scottsdale, AZNPI 1619123528

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Intersect ENT, Inc. at 35.9% of the total. Reporting peaked in 2019 at $5,352 and has fallen 91.1% since, to $474 in 2025.

$8,155in general payments, 2019–2025

Across 93 payments — averaging $87.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • Stryker$1K
  • Globus Medical$914
  • Medical Device Business Services, Inc.$487
  • Lima USA, Inc.$357
  • Sanofi$334
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$1001%
  • Speaking & faculty fees$3574%
  • Travel & lodging$4,29453%
  • Food & beverage$3,40442%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,407,509
Medicare patients
657
Services billed
3,732

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir125$2,838
Methylprednisolone134$914
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen119$393
Doxycycline Monohydrate33$274
Promethazine Hcl110$150
Diazepam93$135

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →